These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28377016)

  • 1. Additional Risks.
    Sattler T; Sattler D
    Dtsch Arztebl Int; 2017 Mar; 114(10):177. PubMed ID: 28377016
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of additional health risks on medical charges and prevalence of diabetes within body mass index categories.
    Musich S; Lu C; McDonald T; Campagne LJ; Edington DW
    Am J Health Promot; 2004; 18(3):264-8. PubMed ID: 14748319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Irrationality and risk--a problem analysis].
    Bergler R
    Zentralbl Hyg Umweltmed; 1995 Apr; 197(1-3):260-75. PubMed ID: 8579715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of risks: social and ecologic aspects].
    Nikonorova EV
    Med Tr Prom Ekol; 1999; (3):10-3. PubMed ID: 10336298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence.
    Kooter AJ; Kostense PJ; Groenewold J; Thijs A; Sattar N; Smulders YM
    Circulation; 2011 Aug; 124(6):741-5. PubMed ID: 21824935
    [No Abstract]   [Full Text] [Related]  

  • 6. Communicating risk reductions. Researchers should present results with both relative and absolute risks.
    Edwards A; Elwyn G; Stott N
    BMJ; 1999 Feb; 318(7183):603; author reply 603-4. PubMed ID: 10189216
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction Model for In-hospital Mortality Should Accurately Predict the Risks of Patients Who Are Truly at Risk.
    Kappen TH; Wanderer JP; Peelen LM; Moons KG; Ehrenfeld JM
    Anesthesiology; 2016 Oct; 125(4):815-6. PubMed ID: 27649433
    [No Abstract]   [Full Text] [Related]  

  • 8. The risks of nanotechnology.
    Williams D
    Med Device Technol; 2005 Nov; 16(9):6, 9-10. PubMed ID: 16438441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Land-use change and emerging public health risks in New Zealand: assessing Giardia risks.
    Winkworth CL
    N Z Med J; 2010 Sep; 123(1322):55-66. PubMed ID: 20930892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between health risks and medical expenditures in a Japanese corporation.
    Lynch WD; Chikamoto Y; Imai K; Lin TF; Kenkel DS; Ozminkowski RJ; Goetzel RZ
    Am J Health Promot; 2005; 19(3 Suppl):238-48. PubMed ID: 15675538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communicating risks through analogies.
    Edwards A
    BMJ; 2003 Sep; 327(7417):749. PubMed ID: 14512490
    [No Abstract]   [Full Text] [Related]  

  • 12. Risks and benefits.
    Nat Nanotechnol; 2006 Dec; 1(3):151. PubMed ID: 18654169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communicating risks at the population level: application of population impact numbers.
    Heller RF; Buchan I; Edwards R; Lyratzopoulos G; McElduff P; St Leger S
    BMJ; 2003 Nov; 327(7424):1162-5. PubMed ID: 14615346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing environmental health risks or net health benefits?
    Tuomisto JT; Pekkanen J
    Scand J Public Health; 2005; 33(3):162-3. PubMed ID: 16040454
    [No Abstract]   [Full Text] [Related]  

  • 15. Nanoecotoxicology: Environmental risks of nanomaterials.
    Scheringer M
    Nat Nanotechnol; 2008 Jun; 3(6):322-3. PubMed ID: 18654538
    [No Abstract]   [Full Text] [Related]  

  • 16. Flexible rather than standardised approaches to communicating risks in health care.
    Edwards A
    Qual Saf Health Care; 2004 Jun; 13(3):169-70. PubMed ID: 15175483
    [No Abstract]   [Full Text] [Related]  

  • 17. Allergy Risk Finder: Hypothesis Generation System for Allergy Risks via Web Service.
    Aramaki E; Shikata S; Watabe E; Miyabe M; Usuda Y; Ayaya S; Kumagaya S
    Stud Health Technol Inform; 2015; 216():1113. PubMed ID: 26262412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
    Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
    Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conceptual framework to assess the risks of human disease following exposure to pathogens. ILSI Risk Science Institute Pathogen Risk Assessment Working Group.
    Risk Anal; 1996 Dec; 16(6):841-8. PubMed ID: 8972112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment in dentistry: health risks of dental amalgam revisited.
    Choi BC
    J Can Dent Assoc; 1996 Apr; 62(4):328-32. PubMed ID: 9011366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.